Fundraising Fox
Find your path to Ed Olhava
Sign up to see every warm intro you have to Ed Olhava
- Paths you didn't know you had: your email and LinkedIn already hold routes to Ed Olhava. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Ed Olhava joined Versant in 2026 as a Scientist in Residence with over 20 years of experience leading small molecule drug discovery programs. He previously served as SVP of Preclinical Development at IFM Therapeutics, advised Third Rock Ventures, was the first medicinal chemist at Epizyme, and co-invented NINLARO at Millennium Pharmaceuticals.
Colleagues at Versant Ventures
Frequently asked questions
- Who is Ed Olhava?
- Ed Olhava joined Versant in 2026 as a Scientist in Residence with over 20 years of experience leading small molecule drug discovery programs. He previously served as SVP of Preclinical Development at IFM Therapeutics, advised Third Rock Ventures, was the first medicinal chemist at Epizyme, and co-invented NINLARO at Millennium Pharmaceuticals.
- Where does Ed Olhava work?
- Ed Olhava is Scientist-in-Residence at Versant Ventures.
About this profile. Compiled from public sources — Versant Ventures's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights